Search research articles
Contact Us
Filters
Showing results (1301-1310 of 1,367) with videos related to
Page
of 137
Sort By:
British Journal of Cancer
|
September 21, 2023
A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer
Daphne Day, John J Park, Jermaine Coward, et al.
Cell Reports. Medicine
|
April 21, 2026
Stereotactic body radiotherapy plus sunitinib vs. sunitinib alone in treatment-naive oligometastatic renal cell carcinoma: A phase 2 clinical trial
Yang Liu, Xin-Yue Zhang, Wen-Su Wei, et al.
Nature Communications
|
April 1, 2024
CD276-dependent efferocytosis by tumor-associated macrophages promotes immune evasion in bladder cancer
Maosheng Cheng, Shuang Chen, Kang Li, et al.
Cancer Communications (London, England)
|
March 4, 2020
Up-regulation of indoleamine 2,3-dioxygenase 1 (IDO1) expression and catalytic activity is associated with immunosuppression and poor prognosis in penile squamous cell carcinoma patients
Qiang-Hua Zhou, Hui Han, Jia-Bin Lu, et al.
European Radiology
|
December 20, 2022
Association of computed tomography-based body composition with survival in metastatic renal cancer patient received immunotherapy: a multicenter, retrospective study
Jun Wang, Pei Dong, Yuanyuan Qu, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
February 17, 2012
[A multicenter, randomized, double-blind, placebo-controlled safety study to evaluate the clinical effects and quality of life of paclitaxel-carboplatin (PC) alone or combined with endostar for advanced non-small cell lung cancer (NSCLC)]
Bao-hui Han, Qing-yu Xiu, Hui-min Wang, et al.
Cancer Management and Research
|
December 11, 2019
Perfusion, Diffusion, Or Brain Tumor Barrier Integrity: Which Represents The Glioma Features Best?
Lin-Feng Yan, Ying-Zhi Sun, Sha-Sha Zhao, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 20, 2024
First-Line PD-1 Blockade Combined With Chemotherapy for Stage IV Penile Squamous Cell Carcinoma: A Multicenter Retrospective Study
Longbin Xiong, Xingli Shan, Huali Ma, et al.
Oncogene
|
July 7, 2022
CircME1 promotes aerobic glycolysis and sunitinib resistance of clear cell renal cell carcinoma through cis-regulation of ME1
Ming-Xiao Zhang, Jia-Li Wang, Cheng-Qiang Mo, et al.
Scientific Reports
|
August 15, 2024
Prediction of non-muscle invasive bladder cancer recurrence using deep learning of pathology image
Guang-Yue Wang, Jing-Fei Zhu, Qi-Chao Wang, et al.
Page
of 137
Search research articles
Search
Showing results (1301-1310 of 1,367) with videos related to
Sort By:
Page
of 137
British Journal of Cancer
|
September 21, 2023
A first-in-human phase 1 study of nofazinlimab, an anti-PD-1 antibody, in advanced solid tumors and in combination with regorafenib in metastatic colorectal cancer
Daphne Day, John J Park, Jermaine Coward, et al.
Cell Reports. Medicine
|
April 21, 2026
Stereotactic body radiotherapy plus sunitinib vs. sunitinib alone in treatment-naive oligometastatic renal cell carcinoma: A phase 2 clinical trial
Yang Liu, Xin-Yue Zhang, Wen-Su Wei, et al.
Nature Communications
|
April 1, 2024
CD276-dependent efferocytosis by tumor-associated macrophages promotes immune evasion in bladder cancer
Maosheng Cheng, Shuang Chen, Kang Li, et al.
Cancer Communications (London, England)
|
March 4, 2020
Up-regulation of indoleamine 2,3-dioxygenase 1 (IDO1) expression and catalytic activity is associated with immunosuppression and poor prognosis in penile squamous cell carcinoma patients
Qiang-Hua Zhou, Hui Han, Jia-Bin Lu, et al.
European Radiology
|
December 20, 2022
Association of computed tomography-based body composition with survival in metastatic renal cancer patient received immunotherapy: a multicenter, retrospective study
Jun Wang, Pei Dong, Yuanyuan Qu, et al.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|
February 17, 2012
[A multicenter, randomized, double-blind, placebo-controlled safety study to evaluate the clinical effects and quality of life of paclitaxel-carboplatin (PC) alone or combined with endostar for advanced non-small cell lung cancer (NSCLC)]
Bao-hui Han, Qing-yu Xiu, Hui-min Wang, et al.
Cancer Management and Research
|
December 11, 2019
Perfusion, Diffusion, Or Brain Tumor Barrier Integrity: Which Represents The Glioma Features Best?
Lin-Feng Yan, Ying-Zhi Sun, Sha-Sha Zhao, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
December 20, 2024
First-Line PD-1 Blockade Combined With Chemotherapy for Stage IV Penile Squamous Cell Carcinoma: A Multicenter Retrospective Study
Longbin Xiong, Xingli Shan, Huali Ma, et al.
Oncogene
|
July 7, 2022
CircME1 promotes aerobic glycolysis and sunitinib resistance of clear cell renal cell carcinoma through cis-regulation of ME1
Ming-Xiao Zhang, Jia-Li Wang, Cheng-Qiang Mo, et al.
Scientific Reports
|
August 15, 2024
Prediction of non-muscle invasive bladder cancer recurrence using deep learning of pathology image
Guang-Yue Wang, Jing-Fei Zhu, Qi-Chao Wang, et al.
Page
of 137